Tuberculosis: a problem with persistence

Mycobacterium tuberculosis is one of most successful pathogens of mankind, infecting one-third of the global population and claiming two million lives every year. The ability of the bacteria to persist in the form of a long-term asymptomatic infection, referred to as latent tuberculosis, is central to the biology of the disease. The persistence of bacteria in superficially normal tissue was recognized soon after the discovery of the tubercle bacillus, and much of our knowledge about persistent populations of M. tuberculosis dates back to the first half of the last century. Recent advances in microbial genetics and host immunity provide an opportunity for renewed investigation of this persistent threat to human health.

[1]  M. H. Williams,et al.  Treatment of tuberculosis. , 1983, The American review of respiratory disease.

[2]  L. Farer,et al.  The rising age of the tuberculosis patient: a sign of success and failure. , 1980, The Journal of infectious diseases.

[3]  John Chan,et al.  Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2 , 2000, The Journal of experimental medicine.

[4]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[5]  P. Andersen,et al.  Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells , 2000, European journal of immunology.

[6]  Dirk Schnappinger,et al.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L G Wayne,et al.  Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions , 1982, Infection and immunity.

[8]  D. Crane,et al.  Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog , 1996, Journal of bacteriology.

[9]  C. Sohaskey,et al.  Nonreplicating persistence of mycobacterium tuberculosis. , 2001, Annual review of microbiology.

[10]  Christopher J. L. Murray,et al.  Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.

[11]  Dirk Schnappinger,et al.  Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program , 2003, The Journal of experimental medicine.

[12]  I. Orme,et al.  In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.

[13]  J. Deeks,et al.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.

[14]  G. Rook,et al.  Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection , 2000, The Lancet.

[15]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[16]  J. Deeks,et al.  Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.

[17]  W. Jacobs,et al.  Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Bishai,et al.  Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. , 2001, JAMA.

[19]  Alan D. Roberts,et al.  Lack of Protection in Mice and Necrotizing Bronchointerstitial Pneumonia with Bronchiolitis in Guinea Pigs Immunized with Vaccines Directed against the hsp60 Molecule ofMycobacterium tuberculosis , 2000, Infection and Immunity.

[20]  Tuberculosis. Scientific blueprint for tuberculosis drug development. , 2001, Tuberculosis.

[21]  I. Orme,et al.  Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis , 2003, Infection and Immunity.

[22]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[24]  A. Dirksen,et al.  Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. , 2002, The Journal of infectious diseases.

[25]  Gerhard Walzl,et al.  Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection , 2001, Nature Medicine.

[26]  J. Dannenberg Rabbit Model of Tuberculosis , 1994 .

[27]  Tanya Parish,et al.  Deletion of Two-Component Regulatory Systems Increases the Virulence of Mycobacterium tuberculosis , 2003, Infection and Immunity.

[28]  B. Bloom,et al.  Tuberculosis Pathogenesis, Protection, and Control , 1994 .

[29]  David L. Cohn Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection ATS / CDC Statement Committee on Latent Tuberculosis Infection Membership List , June 2000 Co-Chairs , 2015 .

[30]  G W Comstock,et al.  The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.

[31]  D. Smith,et al.  Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia. , 1978, The Journal of infectious diseases.

[32]  JoAnne L. Flynn,et al.  Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.

[33]  V. Deretic,et al.  Effects of cytokines on mycobacterial phagosome maturation. , 1998, Journal of cell science.

[34]  James C. Sacchettini,et al.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase , 2000, Nature.

[35]  C. L. Silva,et al.  Identification and Characterization of Protective T Cells in hsp65 DNA-Vaccinated and Mycobacterium tuberculosis-Infected Mice , 1998, Infection and Immunity.

[36]  Alan D. Roberts,et al.  Persistence and Turnover of Antigen-Specific CD4 T Cells During Chronic Tuberculosis Infection in the Mouse 1 , 2003, The Journal of Immunology.

[37]  D. Golenbock,et al.  Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.

[38]  P. Brennan Foreword from the Co-Editor-in-Chief , 2001 .

[39]  Opie,et al.  Tubercle Bacilli in Latent Tuberculous Lesions in Lung Tissue without Tuberculous Lesions , 1928 .

[40]  D. Mitchison Treatment of Tuberculosis , 1980, Journal of the Royal College of Physicians of London.

[41]  G. Schoolnik,et al.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.

[42]  A. H. Baggenstoss,et al.  The residual infectivity of the primary complex of tuberculosis. , 1938, The American journal of pathology.

[43]  R. Appelberg,et al.  CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. , 2001, American journal of respiratory cell and molecular biology.

[44]  M. Horwitz,et al.  The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease , 1996, Nature Medicine.

[45]  T. Dick,et al.  Analysis of the dormancy-inducible narK2 promoter in Mycobacterium bovis BCG. , 2000, FEMS microbiology letters.

[46]  W. Feldman,et al.  The occurrence of virulent tubercle bacilli in presumably non-tuberculous lung tissue. , 1939, The American journal of pathology.

[47]  A. Khomenko The variability of Mycobacterium tuberculosis in patients with cavitary pulmonary tuberculosis in the course of chemotherapy. , 1987, Tubercle.

[48]  S. Falkow,et al.  Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Strachan,et al.  Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission , 2002, Thorax.

[50]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[51]  J. Wallace The heat resistance of tubercle bacilli in the lungs of infected mice. , 1961, The American review of respiratory disease.

[52]  I. Orme,et al.  Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[53]  R. Johnson,et al.  A Novel Role for the Hypoxia Inducible Transcription Factor HIF-1alpha: Critical Regulation of Inflammatory Cell Function , 2003, Cell cycle.

[54]  A. Aderem,et al.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Martin Tompa,et al.  Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis , 2003, Molecular microbiology.

[56]  Yu-Jin Jung,et al.  Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  W. Bishai,et al.  Construction and Characterization of aMycobacterium tuberculosis Mutant Lacking the Alternate Sigma Factor Gene, sigF , 2000, Infection and Immunity.

[58]  D. Smith,et al.  A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatment. , 1991, Tubercle.

[59]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[60]  Joseph Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .

[61]  J. Casanova,et al.  Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.

[62]  V. Mizrahi,et al.  The Stringent Response of Mycobacterium tuberculosis Is Required for Long-Term Survival , 2000, Journal of bacteriology.

[63]  David G. Russell,et al.  Mycobacterium tuberculosis: here today, and here tomorrow , 2001, Nature Reviews Molecular Cell Biology.

[64]  Robertson He The Persistence of Tuberculous Infections , 1933 .

[65]  N. Reiner,et al.  Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. , 1998, Journal of immunology.

[66]  J. Betts,et al.  In Situ Detection of Mycobacterium tuberculosis Transcripts in Human Lung Granulomas Reveals Differential Gene Expression in Necrotic Lesions , 2002, Infection and Immunity.

[67]  A. Myers,et al.  Non-human primates: a model for tuberculosis research. , 2003, Tuberculosis.

[68]  T. Dick,et al.  Up-regulation of narX, encoding a putative 'fused nitrate reductase' in anaerobic dormant Mycobacterium bovis BCG. , 1999, FEMS microbiology letters.

[69]  Christopher Dye,et al.  Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .

[70]  R. Rees,et al.  Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. , 1961, British journal of experimental pathology.

[71]  D. Snider,et al.  Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. , 2015, The American review of respiratory disease.

[72]  Christopher Dye,et al.  Low access to a highly effective therapy: a challenge for international tuberculosis control. , 2002, Bulletin of the World Health Organization.

[73]  D B Kell,et al.  A bacterial cytokine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  D. McMurray,et al.  Disease model: pulmonary tuberculosis. , 2001, Trends in molecular medicine.

[75]  D. Smith,et al.  Pathogenesis of tuberculosis: pathway to apical localization. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[76]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[77]  J. Flynn,et al.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.

[78]  V. Deretic,et al.  Mycobacterium tuberculosis signal transduction system required for persistent infections , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[80]  S. Kaufmann,et al.  How can immunology contribute to the control of tuberculosis? , 2001, Nature Reviews Immunology.

[81]  C. Fritz,et al.  Dependence of Mycobacterium bovis BCG on Anaerobic Nitrate Reductase for Persistence Is Tissue Specific , 2002, Infection and Immunity.

[82]  N. Federspiel,et al.  Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. , 2000, Science.

[83]  W W Stead,et al.  Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? , 2015, The American review of respiratory disease.

[84]  H. Much Über die granuläre, nach Ziehl nicht färbbare Form des Tuberkulosevirus , 1907, Beiträge zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung.

[85]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[86]  C. Harding,et al.  Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. , 1998, Cellular immunology.

[87]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[88]  P. Schlesinger,et al.  Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. , 1998, Journal of immunology.

[89]  H. Robertson THE PERSISTENCE OF TUBERCULOUS INFECTIONS , 1934, The American journal of pathology.

[90]  E. Pamer,et al.  CD8 T cell responses to infectious pathogens. , 2003, Annual review of immunology.

[91]  K. Moelling,et al.  Therapy of tuberculosis in mice by DNA vaccination , 1999, Nature.

[92]  N. Reiner,et al.  The 19-kDa Mycobacterium tuberculosis Protein Induces Macrophage Apoptosis Through Toll-Like Receptor-21 , 2003, The Journal of Immunology.

[93]  W. Mcdermott,et al.  Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. , 1966 .

[94]  D. Rouse,et al.  Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. , 1998, The Journal of infectious diseases.

[95]  R. Fleischmann,et al.  Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative σ factor, SigH , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[96]  O. Schwartz,et al.  DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.

[97]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[98]  S. Sakaguchi Regulatory T cells: mediating compromises between host and parasite , 2003, Nature Immunology.

[99]  H. M. Vandiviere,et al.  THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*: II. THE DEATH AND RESURRECTION , 1956, The American journal of the medical sciences.

[100]  J. Flynn,et al.  CD8+ CTL from Lungs of Mycobacterium tuberculosis-Infected Mice Express Perforin In Vivo and Lyse Infected Macrophages1 , 2000, The Journal of Immunology.